Based on the Semler Scientific Inc stock forecast from 1 analysts, the average analyst target price for Semler Scientific Inc is USD 40.00 over the next 12 months. Semler Scientific Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Semler Scientific Inc is Slightly Bullish , which is based on 7 positive signals and 4 negative signals. At the last closing, Semler Scientific Inc’s stock price was USD 66.43. Semler Scientific Inc’s stock price has changed by +46.64% over the past week, +146.04% over the past month and +79.83% over the last year.
No recent analyst target price found for Semler Scientific Inc
No recent average analyst rating found for Semler Scientific Inc
Company Overview Semler Scientific Inc
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. Read Less
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use bloo...Read More
Frequently Asked Questions About Semler Scientific Inc (SMLR) Stock
Based on ratings from 1 analysts Semler Scientific Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on SMLR's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for SMLR is USD 40.00 over the next 12 months. The maximum analyst target price is USD 40 while the minimum anlayst target price is USD 40.
SMLR stock's Price/Earning ratio is 15.11.
Our analysis grades SMLR stock's Price / Earning ratio at F. This means that SMLR stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this SMLR may be fairly valued for its sector
The last closing price of SMLR's stock was USD 66.43.
The most recent market capitalization for SMLR is USD 0.21B.
Based on targets from 1 analysts, the average taret price for SMLR is projected at USD 40.00 over the next 12 months.
This means that SMLR's stock price may go down by -39.79% over the next 12 months.
We can't find any ETFs which contains Semler Scientific Inc's stock.
As per our most recent records Semler Scientific Inc has 92 Employees.
Semler Scientific Inc's registered address is 2340-2348 Walsh Avenue, Santa Clara, CA, United States, 95051.
You can get more information about it from Semler Scientific Inc's website at https://www.semlerscientific.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Semler Scientific Inc (SMLR) Stock
Based on ratings from 1 analysts Semler Scientific Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on SMLR's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for SMLR is USD 40.00 over the next 12 months. The maximum analyst target price is USD 40 while the minimum anlayst target price is USD 40.
SMLR stock's Price/Earning ratio is 15.11.
Our analysis grades SMLR stock's Price / Earning ratio at F. This means that SMLR stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this SMLR may be fairly valued for its sector
The last closing price of SMLR's stock was USD 66.43.
The most recent market capitalization for SMLR is USD 0.21B.
Based on targets from 1 analysts, the average taret price for SMLR is projected at USD 40.00 over the next 12 months.
This means that SMLR's stock price may go down by -39.79% over the next 12 months.
We can't find any ETFs which contains Semler Scientific Inc's stock.
As per our most recent records Semler Scientific Inc has 92 Employees.
Semler Scientific Inc's registered address is 2340-2348 Walsh Avenue, Santa Clara, CA, United States, 95051.
You can get more information about it from Semler Scientific Inc's website at https://www.semlerscientific.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SMLR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
